Division of Clinical Research and Trials

• 03/27/20
  Marketing approval of NS-065/NCNP-01 (“viltolarsen”) for the treatment of Duchenne muscular dystrophy
• 03/16/20
  Start of operation of a pathological diagnosis network and verification of an AI diagnosis system
• 12/18/19
  Discovery of unknown cancer features with AI: self-acquisition of novel information on cancer recurrence